This month’s boardroom activity across biotech, diagnostics, CROs, and digital health companies highlights a strategic push for scientific excellence, commercial acumen, and global leadersh
This month saw a flurry of board and advisory appointments across the pharmaceutical and biotech sectors, with organisations strengthening their leadership benches through a mix of seasoned
One area in which March proved to be a busy month was in Board appointments, where both Boards of Directors and Advisory Boards saw a number of interesting additions.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.